Literature DB >> 28868793

Chronic steroid-response pancytopenia and increased bone density due to thromboxane synthase deficiency.

Richa Sharma1, Elizabeth Sierra Potchanant1, Jennifer E Schwartz2, Grzegorz Nalepa3,4,5.   

Abstract

Diagnosis of bone marrow failure (BMF) disorders is challenging but essential for optimal patient management. Here, we report a young adult from nonconsanguineous parents with progressive pancytopenia since childhood, bone pain, increased bone density, and haphazard ossification replacing hematopoiesis within the bone marrow. Sequencing revealed two novel biallelic variants of unknown significance within the thromboxane A synthase gene, TBXAS1 (c.266T > C; c.989T > C), bioinformatically predicted to disrupt the protein. TBXAS1 mutations result in Ghosal hematodiaphyseal dysplasia (OMIM 231095), the autosomal recessive syndrome associated with abnormal bone structure and BMF. Identification of the genetic defect prompted steroid therapy leading to resolution of symptoms.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Ghosal hematodiaphyseal dysplasia (GHDD); TBXAS1; bone marrow failure; pancytopenia

Mesh:

Substances:

Year:  2017        PMID: 28868793     DOI: 10.1002/pbc.26777

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  3 in total

1.  Novel compound heterozygous variants of TBXAS1 presenting with Ghosal hematodiaphyseal dysplasia treated with steroids.

Authors:  Sun Young Kim; Alexander Ing; Shunyou Gong; Kai Lee Yap; Rukhmi Bhat
Journal:  Mol Genet Genomic Med       Date:  2021-02-17       Impact factor: 2.183

Review 2.  Bone fragility in patients affected by congenital diseases non skeletal in origin.

Authors:  L Masi; S Ferrari; M K Javaid; S Papapoulos; D D Pierroz; M L Brandi
Journal:  Orphanet J Rare Dis       Date:  2021-01-06       Impact factor: 4.123

3.  Ghosal Hematodiaphyseal Dysplasia: A Case Report.

Authors:  Marjan Shakiba; Shahin Shamsian; Hamid Malekzadeh; Mehrdad Yasaei
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.